Researchers linked higher weight loss after initiating antiobesity meds to lower risk for revision of hip and knee replacement.

Food companies may be able to satisfy the needs of the growing cohort of GLP-1 medication users while also targeting a ...

Experts say incorporating mental health support into obesity care is critical for effective and sustained outcomes. How can ...

Patients who have significant weight loss with anti-obesity medications after joint replacement show reductions in the risk for revision; however, caution on their use is urged as patients recover.

It’s time to treat obesity as a chronic disease and have Medicare cover these life-changing AOMs. By taking action now, we ...

The Department of Social Services remains committed to exploring policy solutions that maximize health outcomes while maintaining fiscal sustainability ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to ...

While CMS has recently released a memo encouraging Medicare Part D to cover anti-obesity medication, it will only do so if the medication can also help manage diabetes symptoms and reduce the risk ...

Dongxing Xie, MD, PhD, from Central South University in Changsha, China, and colleagues examined the association of the proportion of postoperative weight loss following antiobesity medication use ...